Crizotinib extends survival in ALK-positive advanced NSCLC: Single center experience


ÇUBUKÇU E. , KOCA N., KAÇAN T., DELİGÖNÜL A.

Acta Oncologica Turcica, vol.52, no.3, pp.393-397, 2019 (Other Refereed National Journals)

  • Publication Type: Article / Article
  • Volume: 52 Issue: 3
  • Publication Date: 2019
  • Doi Number: 10.5505/aot.2019.59254
  • Title of Journal : Acta Oncologica Turcica
  • Page Numbers: pp.393-397